nodes	percent_of_prediction	percent_of_DWPC	metapath
Podofilox—Teniposide—hematologic cancer	0.235	0.627	CrCtD
Podofilox—Etoposide—hematologic cancer	0.14	0.373	CrCtD
Podofilox—Etoposide—Teniposide—hematologic cancer	0.135	0.627	CrCrCtD
Podofilox—Teniposide—Etoposide—hematologic cancer	0.0804	0.373	CrCrCtD
Podofilox—TOP2A—hematologic cancer	0.079	0.629	CbGaD
Podofilox—NR3C1—hematologic cancer	0.0466	0.371	CbGaD
Podofilox—TUBA4A—Vincristine—hematologic cancer	0.0299	0.148	CbGbCtD
Podofilox—TOP2A—Idarubicin—hematologic cancer	0.0205	0.101	CbGbCtD
Podofilox—TUBB—Vinorelbine—hematologic cancer	0.0188	0.0931	CbGbCtD
Podofilox—TOP2A—Daunorubicin—hematologic cancer	0.0145	0.0718	CbGbCtD
Podofilox—TOP2A—Teniposide—hematologic cancer	0.0126	0.0624	CbGbCtD
Podofilox—TUBB—Vinblastine—hematologic cancer	0.0116	0.0574	CbGbCtD
Podofilox—TUBB—Vincristine—hematologic cancer	0.0114	0.0564	CbGbCtD
Podofilox—TOP2A—Mitoxantrone—hematologic cancer	0.00881	0.0436	CbGbCtD
Podofilox—TOP2A—Epirubicin—hematologic cancer	0.00713	0.0353	CbGbCtD
Podofilox—TOP2A—Etoposide—hematologic cancer	0.00556	0.0275	CbGbCtD
Podofilox—NR3C1—Triamcinolone—hematologic cancer	0.00526	0.026	CbGbCtD
Podofilox—NR3C1—Betamethasone—hematologic cancer	0.00451	0.0223	CbGbCtD
Podofilox—NR3C1—Prednisolone—hematologic cancer	0.00445	0.022	CbGbCtD
Podofilox—NR3C1—Prednisone—hematologic cancer	0.0042	0.0208	CbGbCtD
Podofilox—TOP2A—Doxorubicin—hematologic cancer	0.00379	0.0188	CbGbCtD
Podofilox—NR3C1—Dexamethasone—hematologic cancer	0.00262	0.013	CbGbCtD
Podofilox—CYP2C19—Bortezomib—hematologic cancer	0.00251	0.0124	CbGbCtD
Podofilox—CYP2C19—Thalidomide—hematologic cancer	0.00219	0.0108	CbGbCtD
Podofilox—CYP2C19—Teniposide—hematologic cancer	0.00209	0.0103	CbGbCtD
Podofilox—CYP3A4—Bexarotene—hematologic cancer	0.00198	0.00981	CbGbCtD
Podofilox—CYP2C19—Ifosfamide—hematologic cancer	0.00193	0.00954	CbGbCtD
Podofilox—CYP3A4—Lomustine—hematologic cancer	0.00184	0.00912	CbGbCtD
Podofilox—CYP3A4—Busulfan—hematologic cancer	0.00184	0.00912	CbGbCtD
Podofilox—CYP2C19—Imatinib—hematologic cancer	0.00184	0.00911	CbGbCtD
Podofilox—CYP3A4—Thiotepa—hematologic cancer	0.00164	0.00813	CbGbCtD
Podofilox—CYP3A4—Methoxsalen—hematologic cancer	0.00128	0.00632	CbGbCtD
Podofilox—CYP3A4—Bortezomib—hematologic cancer	0.00121	0.00601	CbGbCtD
Podofilox—CYP2C19—Prednisone—hematologic cancer	0.00121	0.006	CbGbCtD
Podofilox—CYP3A4—Daunorubicin—hematologic cancer	0.00116	0.00575	CbGbCtD
Podofilox—CYP3A4—Cytarabine—hematologic cancer	0.00103	0.00507	CbGbCtD
Podofilox—CYP3A4—Teniposide—hematologic cancer	0.00101	0.005	CbGbCtD
Podofilox—CYP3A4—Ifosfamide—hematologic cancer	0.000932	0.00461	CbGbCtD
Podofilox—CYP3A4—Imatinib—hematologic cancer	0.00089	0.00441	CbGbCtD
Podofilox—CYP3A4—Ruxolitinib—hematologic cancer	0.000838	0.00415	CbGbCtD
Podofilox—CYP3A4—Nilotinib—hematologic cancer	0.000809	0.004	CbGbCtD
Podofilox—CYP3A4—Vinorelbine—hematologic cancer	0.000802	0.00397	CbGbCtD
Podofilox—CYP2C19—Dexamethasone—hematologic cancer	0.000757	0.00375	CbGbCtD
Podofilox—TUBA4A—hematopoietic system—hematologic cancer	0.000739	0.0872	CbGeAlD
Podofilox—CYP3A4—Triamcinolone—hematologic cancer	0.000734	0.00363	CbGbCtD
Podofilox—CYP3A4—Dasatinib—hematologic cancer	0.000715	0.00354	CbGbCtD
Podofilox—CYP3A4—Mitoxantrone—hematologic cancer	0.000706	0.0035	CbGbCtD
Podofilox—CYP3A4—Betamethasone—hematologic cancer	0.000629	0.00312	CbGbCtD
Podofilox—CYP3A4—Prednisolone—hematologic cancer	0.000621	0.00307	CbGbCtD
Podofilox—CYP3A4—Prednisone—hematologic cancer	0.000586	0.0029	CbGbCtD
Podofilox—TUBA4A—gonad—hematologic cancer	0.000562	0.0663	CbGeAlD
Podofilox—CYP3A4—Irinotecan—hematologic cancer	0.000556	0.00275	CbGbCtD
Podofilox—Etoposide—TOP2B—hematologic cancer	0.000539	0.268	CrCbGaD
Podofilox—CYP3A4—Vinblastine—hematologic cancer	0.000494	0.00245	CbGbCtD
Podofilox—Teniposide—NCOA3—hematologic cancer	0.000491	0.244	CrCbGaD
Podofilox—TUBA4A—blood—hematologic cancer	0.00049	0.0578	CbGeAlD
Podofilox—CYP3A4—Vincristine—hematologic cancer	0.000486	0.00241	CbGbCtD
Podofilox—TUBA4A—bone marrow—hematologic cancer	0.000474	0.0559	CbGeAlD
Podofilox—CYP3A4—Etoposide—hematologic cancer	0.000445	0.0022	CbGbCtD
Podofilox—TUBA4A—lung—hematologic cancer	0.000429	0.0507	CbGeAlD
Podofilox—TUBA4A—testis—hematologic cancer	0.000405	0.0478	CbGeAlD
Podofilox—CYP3A4—Dexamethasone—hematologic cancer	0.000366	0.00181	CbGbCtD
Podofilox—TOP2A—blood—hematologic cancer	0.000362	0.0427	CbGeAlD
Podofilox—TUBB—blood—hematologic cancer	0.000359	0.0424	CbGeAlD
Podofilox—TOP2A—bone marrow—hematologic cancer	0.00035	0.0414	CbGeAlD
Podofilox—TUBB—bone marrow—hematologic cancer	0.000347	0.041	CbGeAlD
Podofilox—CYP2C19—hematopoietic system—hematologic cancer	0.000321	0.0379	CbGeAlD
Podofilox—TOP2A—lung—hematologic cancer	0.000318	0.0375	CbGeAlD
Podofilox—TUBB—lung—hematologic cancer	0.000315	0.0371	CbGeAlD
Podofilox—CYP3A4—Doxorubicin—hematologic cancer	0.000304	0.0015	CbGbCtD
Podofilox—TOP2A—testis—hematologic cancer	0.0003	0.0354	CbGeAlD
Podofilox—TUBB—testis—hematologic cancer	0.000297	0.035	CbGeAlD
Podofilox—TUBA4A—lymph node—hematologic cancer	0.000294	0.0347	CbGeAlD
Podofilox—NR3C1—hematopoietic system—hematologic cancer	0.000251	0.0296	CbGeAlD
Podofilox—TOP2A—lymph node—hematologic cancer	0.000217	0.0256	CbGeAlD
Podofilox—TUBB—lymph node—hematologic cancer	0.000215	0.0254	CbGeAlD
Podofilox—CYP2C19—blood—hematologic cancer	0.000213	0.0251	CbGeAlD
Podofilox—NR3C1—gonad—hematologic cancer	0.000191	0.0225	CbGeAlD
Podofilox—CYP3A4—hematopoietic system—hematologic cancer	0.00019	0.0224	CbGeAlD
Podofilox—NR3C1—blood—hematologic cancer	0.000166	0.0196	CbGeAlD
Podofilox—NR3C1—bone marrow—hematologic cancer	0.000161	0.019	CbGeAlD
Podofilox—Etoposide—ABCC3—hematologic cancer	0.000149	0.074	CrCbGaD
Podofilox—NR3C1—lung—hematologic cancer	0.000146	0.0172	CbGeAlD
Podofilox—Teniposide—TOP2A—hematologic cancer	0.000143	0.071	CrCbGaD
Podofilox—Etoposide—GSTT1—hematologic cancer	0.000142	0.0704	CrCbGaD
Podofilox—NR3C1—testis—hematologic cancer	0.000138	0.0162	CbGeAlD
Podofilox—Etoposide—UGT1A1—hematologic cancer	0.000129	0.064	CrCbGaD
Podofilox—CYP3A4—blood—hematologic cancer	0.000126	0.0148	CbGeAlD
Podofilox—Etoposide—GSTP1—hematologic cancer	0.000112	0.0557	CrCbGaD
Podofilox—Etoposide—TOP2A—hematologic cancer	0.000106	0.0526	CrCbGaD
Podofilox—NR3C1—lymph node—hematologic cancer	9.97e-05	0.0118	CbGeAlD
Podofilox—Teniposide—ABCG2—hematologic cancer	9.75e-05	0.0485	CrCbGaD
Podofilox—TUBB—Menadione—Thalidomide—hematologic cancer	9.09e-05	0.0731	CbGdCrCtD
Podofilox—TOP2A—Nilotinib—Imatinib—hematologic cancer	7.46e-05	0.06	CbGdCrCtD
Podofilox—Etoposide—ABCG2—hematologic cancer	7.23e-05	0.036	CrCbGaD
Podofilox—TUBB—Azacitidine—Pentostatin—hematologic cancer	4.65e-05	0.0374	CbGdCrCtD
Podofilox—TUBB—Azacitidine—Clofarabine—hematologic cancer	4.15e-05	0.0334	CbGdCrCtD
Podofilox—TOP2A—Topotecan—Irinotecan—hematologic cancer	4.14e-05	0.0333	CbGdCrCtD
Podofilox—TOP2A—Etoposide—Teniposide—hematologic cancer	4.11e-05	0.0331	CbGdCrCtD
Podofilox—TUBB—Azacitidine—Nelarabine—hematologic cancer	3.9e-05	0.0314	CbGdCrCtD
Podofilox—TOP2A—Vindesine—Vinorelbine—hematologic cancer	3.7e-05	0.0298	CbGdCrCtD
Podofilox—TUBB—Azacitidine—Fludarabine—hematologic cancer	3.04e-05	0.0245	CbGdCrCtD
Podofilox—Etoposide—ABCB1—hematologic cancer	3.01e-05	0.015	CrCbGaD
Podofilox—Oedema—Mitoxantrone—hematologic cancer	3e-05	0.000704	CcSEcCtD
Podofilox—Dermatitis bullous—Epirubicin—hematologic cancer	2.98e-05	0.000699	CcSEcCtD
Podofilox—Pain—Thiotepa—hematologic cancer	2.97e-05	0.000697	CcSEcCtD
Podofilox—Vomiting—Nilotinib—hematologic cancer	2.97e-05	0.000697	CcSEcCtD
Podofilox—TOP2A—Vindesine—Vinblastine—hematologic cancer	2.96e-05	0.0238	CbGdCrCtD
Podofilox—TOP2A—Vindesine—Vincristine—hematologic cancer	2.96e-05	0.0238	CbGdCrCtD
Podofilox—Vomiting—Imatinib—hematologic cancer	2.95e-05	0.000693	CcSEcCtD
Podofilox—Pruritus—Melphalan—hematologic cancer	2.94e-05	0.000691	CcSEcCtD
Podofilox—Rash—Nilotinib—hematologic cancer	2.94e-05	0.000691	CcSEcCtD
Podofilox—Dermatitis—Nilotinib—hematologic cancer	2.94e-05	0.000691	CcSEcCtD
Podofilox—Rash—Imatinib—hematologic cancer	2.93e-05	0.000687	CcSEcCtD
Podofilox—Headache—Nilotinib—hematologic cancer	2.92e-05	0.000687	CcSEcCtD
Podofilox—Dermatitis—Imatinib—hematologic cancer	2.92e-05	0.000687	CcSEcCtD
Podofilox—Oedema—Gemcitabine—hematologic cancer	2.92e-05	0.000686	CcSEcCtD
Podofilox—Insomnia—Carmustine—hematologic cancer	2.92e-05	0.000685	CcSEcCtD
Podofilox—Skin disorder—Mitoxantrone—hematologic cancer	2.91e-05	0.000684	CcSEcCtD
Podofilox—Headache—Imatinib—hematologic cancer	2.91e-05	0.000683	CcSEcCtD
Podofilox—Haemoglobin—Betamethasone—hematologic cancer	2.9e-05	0.000682	CcSEcCtD
Podofilox—Haemoglobin—Dexamethasone—hematologic cancer	2.9e-05	0.000682	CcSEcCtD
Podofilox—Vomiting—Cladribine—hematologic cancer	2.9e-05	0.000681	CcSEcCtD
Podofilox—Paraesthesia—Carmustine—hematologic cancer	2.9e-05	0.00068	CcSEcCtD
Podofilox—Dizziness—Vinblastine—hematologic cancer	2.89e-05	0.000679	CcSEcCtD
Podofilox—Insomnia—Alitretinoin—hematologic cancer	2.89e-05	0.000679	CcSEcCtD
Podofilox—Haemorrhage—Dexamethasone—hematologic cancer	2.89e-05	0.000678	CcSEcCtD
Podofilox—Haemorrhage—Betamethasone—hematologic cancer	2.89e-05	0.000678	CcSEcCtD
Podofilox—Rash—Cladribine—hematologic cancer	2.88e-05	0.000675	CcSEcCtD
Podofilox—TUBB—Azacitidine—Gemcitabine—hematologic cancer	2.87e-05	0.0231	CbGdCrCtD
Podofilox—TUBB—Azacitidine—Cytarabine—hematologic cancer	2.87e-05	0.0231	CbGdCrCtD
Podofilox—Dermatitis—Cladribine—hematologic cancer	2.87e-05	0.000675	CcSEcCtD
Podofilox—Pain—Thalidomide—hematologic cancer	2.87e-05	0.000674	CcSEcCtD
Podofilox—Paraesthesia—Alitretinoin—hematologic cancer	2.87e-05	0.000674	CcSEcCtD
Podofilox—Pruritus—Lenalidomide—hematologic cancer	2.86e-05	0.000672	CcSEcCtD
Podofilox—Headache—Cladribine—hematologic cancer	2.86e-05	0.000671	CcSEcCtD
Podofilox—TOP2A—Floxuridine—Pentostatin—hematologic cancer	2.85e-05	0.0229	CbGdCrCtD
Podofilox—Skin disorder—Gemcitabine—hematologic cancer	2.84e-05	0.000666	CcSEcCtD
Podofilox—Paraesthesia—Ifosfamide—hematologic cancer	2.84e-05	0.000666	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—hematologic cancer	2.82e-05	0.000662	CcSEcCtD
Podofilox—TUBB—Azacitidine—Cladribine—hematologic cancer	2.8e-05	0.0225	CbGdCrCtD
Podofilox—TOP2A—Doxorubicin—Daunorubicin—hematologic cancer	2.79e-05	0.0225	CbGdCrCtD
Podofilox—TOP2A—Epirubicin—Daunorubicin—hematologic cancer	2.79e-05	0.0225	CbGdCrCtD
Podofilox—TOP2A—Idarubicin—Daunorubicin—hematologic cancer	2.79e-05	0.0225	CbGdCrCtD
Podofilox—Insomnia—Vincristine—hematologic cancer	2.78e-05	0.000654	CcSEcCtD
Podofilox—Vomiting—Vinblastine—hematologic cancer	2.78e-05	0.000653	CcSEcCtD
Podofilox—Erythema—Triamcinolone—hematologic cancer	2.77e-05	0.000651	CcSEcCtD
Podofilox—Paraesthesia—Vincristine—hematologic cancer	2.76e-05	0.000649	CcSEcCtD
Podofilox—Pain—Carmustine—hematologic cancer	2.76e-05	0.000648	CcSEcCtD
Podofilox—Dermatitis bullous—Doxorubicin—hematologic cancer	2.75e-05	0.000647	CcSEcCtD
Podofilox—Headache—Vinblastine—hematologic cancer	2.74e-05	0.000644	CcSEcCtD
Podofilox—Pain—Alitretinoin—hematologic cancer	2.73e-05	0.000642	CcSEcCtD
Podofilox—Oedema—Cisplatin—hematologic cancer	2.72e-05	0.000639	CcSEcCtD
Podofilox—Insomnia—Irinotecan—hematologic cancer	2.71e-05	0.000637	CcSEcCtD
Podofilox—Pain—Ifosfamide—hematologic cancer	2.7e-05	0.000634	CcSEcCtD
Podofilox—Paraesthesia—Irinotecan—hematologic cancer	2.69e-05	0.000632	CcSEcCtD
Podofilox—Paraesthesia—Mitoxantrone—hematologic cancer	2.69e-05	0.000632	CcSEcCtD
Podofilox—Dizziness—Lenalidomide—hematologic cancer	2.68e-05	0.000628	CcSEcCtD
Podofilox—Vomiting—Melphalan—hematologic cancer	2.65e-05	0.000621	CcSEcCtD
Podofilox—Skin disorder—Cisplatin—hematologic cancer	2.64e-05	0.000621	CcSEcCtD
Podofilox—Insomnia—Gemcitabine—hematologic cancer	2.64e-05	0.00062	CcSEcCtD
Podofilox—Dizziness—Hydroxyurea—hematologic cancer	2.64e-05	0.000619	CcSEcCtD
Podofilox—Pruritus—Bortezomib—hematologic cancer	2.63e-05	0.000619	CcSEcCtD
Podofilox—Pain—Vincristine—hematologic cancer	2.63e-05	0.000618	CcSEcCtD
Podofilox—Rash—Melphalan—hematologic cancer	2.62e-05	0.000616	CcSEcCtD
Podofilox—Paraesthesia—Gemcitabine—hematologic cancer	2.62e-05	0.000616	CcSEcCtD
Podofilox—Dermatitis—Melphalan—hematologic cancer	2.62e-05	0.000616	CcSEcCtD
Podofilox—Pruritus—Bleomycin—hematologic cancer	2.61e-05	0.000614	CcSEcCtD
Podofilox—Dry skin—Epirubicin—hematologic cancer	2.61e-05	0.000612	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Etoposide—hematologic cancer	2.58e-05	0.000607	CcSEcCtD
Podofilox—Vomiting—Lenalidomide—hematologic cancer	2.57e-05	0.000604	CcSEcCtD
Podofilox—Pruritus—Vinorelbine—hematologic cancer	2.57e-05	0.000604	CcSEcCtD
Podofilox—Pain—Irinotecan—hematologic cancer	2.56e-05	0.000602	CcSEcCtD
Podofilox—Pain—Mitoxantrone—hematologic cancer	2.56e-05	0.000602	CcSEcCtD
Podofilox—Rash—Lenalidomide—hematologic cancer	2.55e-05	0.000599	CcSEcCtD
Podofilox—Dermatitis—Lenalidomide—hematologic cancer	2.55e-05	0.000598	CcSEcCtD
Podofilox—Vomiting—Hydroxyurea—hematologic cancer	2.54e-05	0.000596	CcSEcCtD
Podofilox—Headache—Lenalidomide—hematologic cancer	2.53e-05	0.000595	CcSEcCtD
Podofilox—Haemoglobin—Prednisone—hematologic cancer	2.53e-05	0.000594	CcSEcCtD
Podofilox—Haemorrhage—Prednisone—hematologic cancer	2.52e-05	0.000591	CcSEcCtD
Podofilox—Rash—Hydroxyurea—hematologic cancer	2.52e-05	0.000591	CcSEcCtD
Podofilox—Erythema—Dexamethasone—hematologic cancer	2.51e-05	0.000591	CcSEcCtD
Podofilox—Erythema—Betamethasone—hematologic cancer	2.51e-05	0.000591	CcSEcCtD
Podofilox—Dermatitis—Hydroxyurea—hematologic cancer	2.51e-05	0.00059	CcSEcCtD
Podofilox—Headache—Hydroxyurea—hematologic cancer	2.5e-05	0.000587	CcSEcCtD
Podofilox—Pain—Gemcitabine—hematologic cancer	2.5e-05	0.000586	CcSEcCtD
Podofilox—Dizziness—Bortezomib—hematologic cancer	2.46e-05	0.000578	CcSEcCtD
Podofilox—Oedema—Prednisolone—hematologic cancer	2.46e-05	0.000578	CcSEcCtD
Podofilox—Pruritus—Thiotepa—hematologic cancer	2.46e-05	0.000577	CcSEcCtD
Podofilox—Paraesthesia—Cisplatin—hematologic cancer	2.44e-05	0.000574	CcSEcCtD
Podofilox—Skin disorder—Etoposide—hematologic cancer	2.42e-05	0.000569	CcSEcCtD
Podofilox—Dry skin—Doxorubicin—hematologic cancer	2.41e-05	0.000566	CcSEcCtD
Podofilox—Dizziness—Vinorelbine—hematologic cancer	2.4e-05	0.000565	CcSEcCtD
Podofilox—TOP2A—Menadione—Thalidomide—hematologic cancer	2.38e-05	0.0191	CbGdCrCtD
Podofilox—Pruritus—Thalidomide—hematologic cancer	2.38e-05	0.000558	CcSEcCtD
Podofilox—Vomiting—Bortezomib—hematologic cancer	2.37e-05	0.000556	CcSEcCtD
Podofilox—Vomiting—Bleomycin—hematologic cancer	2.35e-05	0.000552	CcSEcCtD
Podofilox—Rash—Bortezomib—hematologic cancer	2.35e-05	0.000551	CcSEcCtD
Podofilox—Dermatitis—Bortezomib—hematologic cancer	2.35e-05	0.000551	CcSEcCtD
Podofilox—Headache—Bortezomib—hematologic cancer	2.33e-05	0.000548	CcSEcCtD
Podofilox—Rash—Bleomycin—hematologic cancer	2.33e-05	0.000547	CcSEcCtD
Podofilox—Pain—Cisplatin—hematologic cancer	2.33e-05	0.000547	CcSEcCtD
Podofilox—Dermatitis—Bleomycin—hematologic cancer	2.33e-05	0.000547	CcSEcCtD
Podofilox—Vomiting—Vinorelbine—hematologic cancer	2.31e-05	0.000543	CcSEcCtD
Podofilox—Dizziness—Thiotepa—hematologic cancer	2.3e-05	0.000539	CcSEcCtD
Podofilox—Rash—Vinorelbine—hematologic cancer	2.29e-05	0.000538	CcSEcCtD
Podofilox—Dermatitis—Vinorelbine—hematologic cancer	2.29e-05	0.000538	CcSEcCtD
Podofilox—Headache—Vinorelbine—hematologic cancer	2.28e-05	0.000535	CcSEcCtD
Podofilox—Immune system disorder—Prednisone—hematologic cancer	2.27e-05	0.000534	CcSEcCtD
Podofilox—Oedema—Triamcinolone—hematologic cancer	2.26e-05	0.000531	CcSEcCtD
Podofilox—Pruritus—Alitretinoin—hematologic cancer	2.26e-05	0.000531	CcSEcCtD
Podofilox—Paraesthesia—Etoposide—hematologic cancer	2.24e-05	0.000526	CcSEcCtD
Podofilox—Pruritus—Ifosfamide—hematologic cancer	2.23e-05	0.000525	CcSEcCtD
Podofilox—Haematuria—Methotrexate—hematologic cancer	2.23e-05	0.000524	CcSEcCtD
Podofilox—Insomnia—Prednisolone—hematologic cancer	2.22e-05	0.000522	CcSEcCtD
Podofilox—Dizziness—Thalidomide—hematologic cancer	2.22e-05	0.000521	CcSEcCtD
Podofilox—Paraesthesia—Prednisolone—hematologic cancer	2.21e-05	0.000519	CcSEcCtD
Podofilox—Vomiting—Thiotepa—hematologic cancer	2.21e-05	0.000518	CcSEcCtD
Podofilox—Erythema—Prednisone—hematologic cancer	2.19e-05	0.000514	CcSEcCtD
Podofilox—Rash—Thiotepa—hematologic cancer	2.19e-05	0.000514	CcSEcCtD
Podofilox—Dermatitis—Thiotepa—hematologic cancer	2.19e-05	0.000514	CcSEcCtD
Podofilox—Headache—Thiotepa—hematologic cancer	2.17e-05	0.000511	CcSEcCtD
Podofilox—TOP2A—Cladribine—Pentostatin—hematologic cancer	2.16e-05	0.0174	CbGdCrCtD
Podofilox—Vomiting—Thalidomide—hematologic cancer	2.13e-05	0.000501	CcSEcCtD
Podofilox—Dizziness—Carmustine—hematologic cancer	2.13e-05	0.000501	CcSEcCtD
Podofilox—Pain—Etoposide—hematologic cancer	2.13e-05	0.000501	CcSEcCtD
Podofilox—TOP2A—Daunorubicin—Idarubicin—hematologic cancer	2.12e-05	0.017	CbGdCrCtD
Podofilox—TOP2A—Doxorubicin—Idarubicin—hematologic cancer	2.12e-05	0.017	CbGdCrCtD
Podofilox—TOP2A—Epirubicin—Idarubicin—hematologic cancer	2.12e-05	0.017	CbGdCrCtD
Podofilox—Rash—Thalidomide—hematologic cancer	2.12e-05	0.000497	CcSEcCtD
Podofilox—Dermatitis—Thalidomide—hematologic cancer	2.12e-05	0.000497	CcSEcCtD
Podofilox—Haemoglobin—Methotrexate—hematologic cancer	2.11e-05	0.000496	CcSEcCtD
Podofilox—Dizziness—Alitretinoin—hematologic cancer	2.11e-05	0.000496	CcSEcCtD
Podofilox—Headache—Thalidomide—hematologic cancer	2.1e-05	0.000494	CcSEcCtD
Podofilox—Pain—Prednisolone—hematologic cancer	2.1e-05	0.000494	CcSEcCtD
Podofilox—Haemorrhage—Methotrexate—hematologic cancer	2.1e-05	0.000494	CcSEcCtD
Podofilox—Haematuria—Epirubicin—hematologic cancer	2.09e-05	0.000491	CcSEcCtD
Podofilox—Dizziness—Ifosfamide—hematologic cancer	2.09e-05	0.00049	CcSEcCtD
Podofilox—Pruritus—Gemcitabine—hematologic cancer	2.07e-05	0.000485	CcSEcCtD
Podofilox—Oedema—Betamethasone—hematologic cancer	2.05e-05	0.000482	CcSEcCtD
Podofilox—Oedema—Dexamethasone—hematologic cancer	2.05e-05	0.000482	CcSEcCtD
Podofilox—Vomiting—Carmustine—hematologic cancer	2.05e-05	0.000482	CcSEcCtD
Podofilox—Insomnia—Triamcinolone—hematologic cancer	2.05e-05	0.00048	CcSEcCtD
Podofilox—Dizziness—Vincristine—hematologic cancer	2.04e-05	0.000478	CcSEcCtD
Podofilox—Rash—Carmustine—hematologic cancer	2.03e-05	0.000477	CcSEcCtD
Podofilox—Dermatitis—Carmustine—hematologic cancer	2.03e-05	0.000477	CcSEcCtD
Podofilox—Vomiting—Alitretinoin—hematologic cancer	2.03e-05	0.000477	CcSEcCtD
Podofilox—Paraesthesia—Triamcinolone—hematologic cancer	2.03e-05	0.000477	CcSEcCtD
Podofilox—Headache—Carmustine—hematologic cancer	2.02e-05	0.000474	CcSEcCtD
Podofilox—Rash—Alitretinoin—hematologic cancer	2.01e-05	0.000473	CcSEcCtD
Podofilox—Dermatitis—Alitretinoin—hematologic cancer	2.01e-05	0.000473	CcSEcCtD
Podofilox—Vomiting—Ifosfamide—hematologic cancer	2.01e-05	0.000471	CcSEcCtD
Podofilox—Headache—Alitretinoin—hematologic cancer	2e-05	0.00047	CcSEcCtD
Podofilox—TOP2A—Vincristine—Vinorelbine—hematologic cancer	2e-05	0.0161	CbGdCrCtD
Podofilox—Rash—Ifosfamide—hematologic cancer	1.99e-05	0.000468	CcSEcCtD
Podofilox—Dermatitis—Ifosfamide—hematologic cancer	1.99e-05	0.000467	CcSEcCtD
Podofilox—Dizziness—Irinotecan—hematologic cancer	1.98e-05	0.000466	CcSEcCtD
Podofilox—Haemoglobin—Epirubicin—hematologic cancer	1.98e-05	0.000464	CcSEcCtD
Podofilox—Haemorrhage—Epirubicin—hematologic cancer	1.97e-05	0.000462	CcSEcCtD
Podofilox—Vomiting—Vincristine—hematologic cancer	1.96e-05	0.00046	CcSEcCtD
Podofilox—Rash—Vincristine—hematologic cancer	1.94e-05	0.000456	CcSEcCtD
Podofilox—Dermatitis—Vincristine—hematologic cancer	1.94e-05	0.000455	CcSEcCtD
Podofilox—Pain—Triamcinolone—hematologic cancer	1.93e-05	0.000454	CcSEcCtD
Podofilox—Haematuria—Doxorubicin—hematologic cancer	1.93e-05	0.000454	CcSEcCtD
Podofilox—Headache—Vincristine—hematologic cancer	1.93e-05	0.000453	CcSEcCtD
Podofilox—TOP2A—Cladribine—Clofarabine—hematologic cancer	1.92e-05	0.0155	CbGdCrCtD
Podofilox—Vomiting—Irinotecan—hematologic cancer	1.91e-05	0.000448	CcSEcCtD
Podofilox—Vomiting—Mitoxantrone—hematologic cancer	1.91e-05	0.000448	CcSEcCtD
Podofilox—Immune system disorder—Methotrexate—hematologic cancer	1.9e-05	0.000446	CcSEcCtD
Podofilox—Rash—Irinotecan—hematologic cancer	1.89e-05	0.000444	CcSEcCtD
Podofilox—Rash—Mitoxantrone—hematologic cancer	1.89e-05	0.000444	CcSEcCtD
Podofilox—Dermatitis—Irinotecan—hematologic cancer	1.89e-05	0.000443	CcSEcCtD
Podofilox—Dermatitis—Mitoxantrone—hematologic cancer	1.89e-05	0.000443	CcSEcCtD
Podofilox—Headache—Mitoxantrone—hematologic cancer	1.88e-05	0.000441	CcSEcCtD
Podofilox—Headache—Irinotecan—hematologic cancer	1.88e-05	0.000441	CcSEcCtD
Podofilox—TOP2A—Vinorelbine—Vincristine—hematologic cancer	1.87e-05	0.015	CbGdCrCtD
Podofilox—TOP2A—Vinorelbine—Vinblastine—hematologic cancer	1.87e-05	0.015	CbGdCrCtD
Podofilox—TOP2A—Teniposide—Etoposide—hematologic cancer	1.86e-05	0.015	CbGdCrCtD
Podofilox—Vomiting—Gemcitabine—hematologic cancer	1.86e-05	0.000436	CcSEcCtD
Podofilox—Insomnia—Dexamethasone—hematologic cancer	1.86e-05	0.000436	CcSEcCtD
Podofilox—Insomnia—Betamethasone—hematologic cancer	1.86e-05	0.000436	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	1.85e-05	0.000435	CcSEcCtD
Podofilox—Paraesthesia—Betamethasone—hematologic cancer	1.84e-05	0.000433	CcSEcCtD
Podofilox—Paraesthesia—Dexamethasone—hematologic cancer	1.84e-05	0.000433	CcSEcCtD
Podofilox—Rash—Gemcitabine—hematologic cancer	1.84e-05	0.000432	CcSEcCtD
Podofilox—Dermatitis—Gemcitabine—hematologic cancer	1.84e-05	0.000432	CcSEcCtD
Podofilox—Erythema—Methotrexate—hematologic cancer	1.83e-05	0.00043	CcSEcCtD
Podofilox—Haemoglobin—Doxorubicin—hematologic cancer	1.83e-05	0.00043	CcSEcCtD
Podofilox—Headache—Gemcitabine—hematologic cancer	1.83e-05	0.00043	CcSEcCtD
Podofilox—Haemorrhage—Doxorubicin—hematologic cancer	1.82e-05	0.000428	CcSEcCtD
Podofilox—TOP2A—Cladribine—Nelarabine—hematologic cancer	1.81e-05	0.0146	CbGdCrCtD
Podofilox—Oedema—Prednisone—hematologic cancer	1.79e-05	0.00042	CcSEcCtD
Podofilox—Immune system disorder—Epirubicin—hematologic cancer	1.78e-05	0.000417	CcSEcCtD
Podofilox—Pruritus—Etoposide—hematologic cancer	1.76e-05	0.000414	CcSEcCtD
Podofilox—Pain—Dexamethasone—hematologic cancer	1.76e-05	0.000412	CcSEcCtD
Podofilox—Pain—Betamethasone—hematologic cancer	1.76e-05	0.000412	CcSEcCtD
Podofilox—Skin disorder—Prednisone—hematologic cancer	1.74e-05	0.000408	CcSEcCtD
Podofilox—Vomiting—Cisplatin—hematologic cancer	1.73e-05	0.000406	CcSEcCtD
Podofilox—Rash—Cisplatin—hematologic cancer	1.72e-05	0.000403	CcSEcCtD
Podofilox—TOP2A—Floxuridine—Cladribine—hematologic cancer	1.72e-05	0.0138	CbGdCrCtD
Podofilox—Dermatitis—Cisplatin—hematologic cancer	1.71e-05	0.000403	CcSEcCtD
Podofilox—Erythema—Epirubicin—hematologic cancer	1.71e-05	0.000402	CcSEcCtD
Podofilox—TOP2A—Clofarabine—Nelarabine—hematologic cancer	1.67e-05	0.0135	CbGdCrCtD
Podofilox—Dizziness—Etoposide—hematologic cancer	1.65e-05	0.000387	CcSEcCtD
Podofilox—Immune system disorder—Doxorubicin—hematologic cancer	1.64e-05	0.000386	CcSEcCtD
Podofilox—Dizziness—Prednisolone—hematologic cancer	1.63e-05	0.000382	CcSEcCtD
Podofilox—Insomnia—Prednisone—hematologic cancer	1.62e-05	0.00038	CcSEcCtD
Podofilox—Paraesthesia—Prednisone—hematologic cancer	1.6e-05	0.000377	CcSEcCtD
Podofilox—TOP2A—Vinblastine—Vinorelbine—hematologic cancer	1.6e-05	0.0129	CbGdCrCtD
Podofilox—Pruritus—Triamcinolone—hematologic cancer	1.6e-05	0.000376	CcSEcCtD
Podofilox—TOP2A—Vincristine—Vinblastine—hematologic cancer	1.6e-05	0.0128	CbGdCrCtD
Podofilox—Vomiting—Etoposide—hematologic cancer	1.59e-05	0.000372	CcSEcCtD
Podofilox—Erythema—Doxorubicin—hematologic cancer	1.58e-05	0.000372	CcSEcCtD
Podofilox—Rash—Etoposide—hematologic cancer	1.57e-05	0.000369	CcSEcCtD
Podofilox—Dermatitis—Etoposide—hematologic cancer	1.57e-05	0.000369	CcSEcCtD
Podofilox—Headache—Etoposide—hematologic cancer	1.56e-05	0.000367	CcSEcCtD
Podofilox—Rash—Prednisolone—hematologic cancer	1.55e-05	0.000364	CcSEcCtD
Podofilox—Dermatitis—Prednisolone—hematologic cancer	1.55e-05	0.000364	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.55e-05	0.000363	CcSEcCtD
Podofilox—Headache—Prednisolone—hematologic cancer	1.54e-05	0.000362	CcSEcCtD
Podofilox—TOP2A—Cytarabine—Clofarabine—hematologic cancer	1.51e-05	0.0122	CbGdCrCtD
Podofilox—Dizziness—Triamcinolone—hematologic cancer	1.5e-05	0.000351	CcSEcCtD
Podofilox—Pruritus—Betamethasone—hematologic cancer	1.45e-05	0.000341	CcSEcCtD
Podofilox—Pruritus—Dexamethasone—hematologic cancer	1.45e-05	0.000341	CcSEcCtD
Podofilox—Skin disorder—Methotrexate—hematologic cancer	1.45e-05	0.000341	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	1.45e-05	0.00034	CcSEcCtD
Podofilox—Vomiting—Triamcinolone—hematologic cancer	1.44e-05	0.000338	CcSEcCtD
Podofilox—Rash—Triamcinolone—hematologic cancer	1.43e-05	0.000335	CcSEcCtD
Podofilox—Dermatitis—Triamcinolone—hematologic cancer	1.42e-05	0.000335	CcSEcCtD
Podofilox—TOP2A—Cytarabine—Nelarabine—hematologic cancer	1.42e-05	0.0114	CbGdCrCtD
Podofilox—Headache—Triamcinolone—hematologic cancer	1.42e-05	0.000333	CcSEcCtD
Podofilox—TOP2A—Cladribine—Fludarabine—hematologic cancer	1.41e-05	0.0114	CbGdCrCtD
Podofilox—Oedema—Epirubicin—hematologic cancer	1.4e-05	0.000328	CcSEcCtD
Podofilox—Skin disorder—Epirubicin—hematologic cancer	1.36e-05	0.000319	CcSEcCtD
Podofilox—Dizziness—Dexamethasone—hematologic cancer	1.36e-05	0.000319	CcSEcCtD
Podofilox—Dizziness—Betamethasone—hematologic cancer	1.36e-05	0.000319	CcSEcCtD
Podofilox—Insomnia—Methotrexate—hematologic cancer	1.35e-05	0.000317	CcSEcCtD
Podofilox—Paraesthesia—Methotrexate—hematologic cancer	1.34e-05	0.000315	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.34e-05	0.000315	CcSEcCtD
Podofilox—TOP2A—Clofarabine—Fludarabine—hematologic cancer	1.31e-05	0.0105	CbGdCrCtD
Podofilox—Vomiting—Betamethasone—hematologic cancer	1.3e-05	0.000306	CcSEcCtD
Podofilox—Vomiting—Dexamethasone—hematologic cancer	1.3e-05	0.000306	CcSEcCtD
Podofilox—Rash—Betamethasone—hematologic cancer	1.29e-05	0.000304	CcSEcCtD
Podofilox—Rash—Dexamethasone—hematologic cancer	1.29e-05	0.000304	CcSEcCtD
Podofilox—Oedema—Doxorubicin—hematologic cancer	1.29e-05	0.000304	CcSEcCtD
Podofilox—Dermatitis—Dexamethasone—hematologic cancer	1.29e-05	0.000304	CcSEcCtD
Podofilox—Dermatitis—Betamethasone—hematologic cancer	1.29e-05	0.000304	CcSEcCtD
Podofilox—Headache—Dexamethasone—hematologic cancer	1.29e-05	0.000302	CcSEcCtD
Podofilox—Headache—Betamethasone—hematologic cancer	1.29e-05	0.000302	CcSEcCtD
Podofilox—TOP2A—Vinblastine—Vincristine—hematologic cancer	1.28e-05	0.0103	CbGdCrCtD
Podofilox—Pain—Methotrexate—hematologic cancer	1.28e-05	0.0003	CcSEcCtD
Podofilox—Pruritus—Prednisone—hematologic cancer	1.26e-05	0.000297	CcSEcCtD
Podofilox—Insomnia—Epirubicin—hematologic cancer	1.26e-05	0.000297	CcSEcCtD
Podofilox—Skin disorder—Doxorubicin—hematologic cancer	1.26e-05	0.000295	CcSEcCtD
Podofilox—Paraesthesia—Epirubicin—hematologic cancer	1.26e-05	0.000295	CcSEcCtD
Podofilox—TOP2A—Clofarabine—Cytarabine—hematologic cancer	1.23e-05	0.00992	CbGdCrCtD
Podofilox—TOP2A—Azacitidine—Pentostatin—hematologic cancer	1.22e-05	0.00979	CbGdCrCtD
Podofilox—TOP2A—Clofarabine—Cladribine—hematologic cancer	1.2e-05	0.00967	CbGdCrCtD
Podofilox—Pain—Epirubicin—hematologic cancer	1.2e-05	0.000281	CcSEcCtD
Podofilox—Dizziness—Prednisone—hematologic cancer	1.18e-05	0.000278	CcSEcCtD
Podofilox—Insomnia—Doxorubicin—hematologic cancer	1.17e-05	0.000275	CcSEcCtD
Podofilox—Paraesthesia—Doxorubicin—hematologic cancer	1.16e-05	0.000273	CcSEcCtD
Podofilox—TOP2A—Gemcitabine—Cytarabine—hematologic cancer	1.14e-05	0.00919	CbGdCrCtD
Podofilox—Vomiting—Prednisone—hematologic cancer	1.14e-05	0.000267	CcSEcCtD
Podofilox—Rash—Prednisone—hematologic cancer	1.13e-05	0.000265	CcSEcCtD
Podofilox—Dermatitis—Prednisone—hematologic cancer	1.13e-05	0.000264	CcSEcCtD
Podofilox—Headache—Prednisone—hematologic cancer	1.12e-05	0.000263	CcSEcCtD
Podofilox—TOP2A—Cytarabine—Fludarabine—hematologic cancer	1.11e-05	0.00894	CbGdCrCtD
Podofilox—Pain—Doxorubicin—hematologic cancer	1.11e-05	0.00026	CcSEcCtD
Podofilox—TOP2A—Azacitidine—Clofarabine—hematologic cancer	1.08e-05	0.00873	CbGdCrCtD
Podofilox—Pruritus—Methotrexate—hematologic cancer	1.06e-05	0.000248	CcSEcCtD
Podofilox—TOP2A—Cytarabine—Gemcitabine—hematologic cancer	1.05e-05	0.00844	CbGdCrCtD
Podofilox—TOP2A—Azacitidine—Nelarabine—hematologic cancer	1.02e-05	0.00821	CbGdCrCtD
Podofilox—Pruritus—Epirubicin—hematologic cancer	9.89e-06	0.000232	CcSEcCtD
Podofilox—Dizziness—Methotrexate—hematologic cancer	9.88e-06	0.000232	CcSEcCtD
Podofilox—TOP2A—Doxorubicin—Epirubicin—hematologic cancer	9.72e-06	0.00783	CbGdCrCtD
Podofilox—TOP2A—Idarubicin—Epirubicin—hematologic cancer	9.72e-06	0.00783	CbGdCrCtD
Podofilox—TOP2A—Daunorubicin—Epirubicin—hematologic cancer	9.72e-06	0.00783	CbGdCrCtD
Podofilox—Vomiting—Methotrexate—hematologic cancer	9.5e-06	0.000223	CcSEcCtD
Podofilox—Rash—Methotrexate—hematologic cancer	9.42e-06	0.000221	CcSEcCtD
Podofilox—Dermatitis—Methotrexate—hematologic cancer	9.41e-06	0.000221	CcSEcCtD
Podofilox—Headache—Methotrexate—hematologic cancer	9.36e-06	0.00022	CcSEcCtD
Podofilox—Dizziness—Epirubicin—hematologic cancer	9.24e-06	0.000217	CcSEcCtD
Podofilox—Pruritus—Doxorubicin—hematologic cancer	9.15e-06	0.000215	CcSEcCtD
Podofilox—TOP2A—Epirubicin—Doxorubicin—hematologic cancer	9e-06	0.00724	CbGdCrCtD
Podofilox—TOP2A—Daunorubicin—Doxorubicin—hematologic cancer	9e-06	0.00724	CbGdCrCtD
Podofilox—TOP2A—Idarubicin—Doxorubicin—hematologic cancer	9e-06	0.00724	CbGdCrCtD
Podofilox—Vomiting—Epirubicin—hematologic cancer	8.89e-06	0.000209	CcSEcCtD
Podofilox—Rash—Epirubicin—hematologic cancer	8.81e-06	0.000207	CcSEcCtD
Podofilox—Dermatitis—Epirubicin—hematologic cancer	8.81e-06	0.000207	CcSEcCtD
Podofilox—Headache—Epirubicin—hematologic cancer	8.76e-06	0.000206	CcSEcCtD
Podofilox—Dizziness—Doxorubicin—hematologic cancer	8.55e-06	0.000201	CcSEcCtD
Podofilox—Vomiting—Doxorubicin—hematologic cancer	8.22e-06	0.000193	CcSEcCtD
Podofilox—Rash—Doxorubicin—hematologic cancer	8.16e-06	0.000192	CcSEcCtD
Podofilox—Dermatitis—Doxorubicin—hematologic cancer	8.15e-06	0.000191	CcSEcCtD
Podofilox—Headache—Doxorubicin—hematologic cancer	8.1e-06	0.00019	CcSEcCtD
Podofilox—TOP2A—Azacitidine—Fludarabine—hematologic cancer	7.96e-06	0.00641	CbGdCrCtD
Podofilox—TOP2A—Azacitidine—Cytarabine—hematologic cancer	7.52e-06	0.00605	CbGdCrCtD
Podofilox—TOP2A—Azacitidine—Gemcitabine—hematologic cancer	7.52e-06	0.00605	CbGdCrCtD
Podofilox—TOP2A—Azacitidine—Cladribine—hematologic cancer	7.33e-06	0.0059	CbGdCrCtD
Podofilox—CYP3A4—Tryptophan metabolism—MDM2—hematologic cancer	6.26e-06	0.000226	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—IL6—hematologic cancer	6.25e-06	0.000226	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—CDKN1B—hematologic cancer	6.24e-06	0.000226	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—RPLP1—hematologic cancer	6.22e-06	0.000225	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—GSTM1—hematologic cancer	6.19e-06	0.000224	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—STAT3—hematologic cancer	6.19e-06	0.000224	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—JUN—hematologic cancer	6.19e-06	0.000224	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—MTR—hematologic cancer	6.15e-06	0.000222	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—MDM2—hematologic cancer	6.11e-06	0.000221	CbGpPWpGaD
Podofilox—CYP2C19—Metapathway biotransformation—GSTM1—hematologic cancer	6.11e-06	0.000221	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—EP300—hematologic cancer	6.11e-06	0.000221	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—CDK2—hematologic cancer	6.1e-06	0.000221	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—FHL2—hematologic cancer	6.09e-06	0.00022	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—CDKN1A—hematologic cancer	6.06e-06	0.000219	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—CCND1—hematologic cancer	5.95e-06	0.000215	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—SRC—hematologic cancer	5.94e-06	0.000215	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—NR0B2—hematologic cancer	5.89e-06	0.000213	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—AR—hematologic cancer	5.88e-06	0.000213	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	5.86e-06	0.000212	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—GSTT1—hematologic cancer	5.85e-06	0.000212	CbGpPWpGaD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—hematologic cancer	5.82e-06	0.000211	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—ATM—hematologic cancer	5.79e-06	0.000209	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—VEGFA—hematologic cancer	5.78e-06	0.000209	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—MAPK3—hematologic cancer	5.77e-06	0.000209	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—AKT1—hematologic cancer	5.77e-06	0.000209	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—CDK4—hematologic cancer	5.77e-06	0.000209	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—EP300—hematologic cancer	5.76e-06	0.000208	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—CDKN1A—hematologic cancer	5.76e-06	0.000208	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—TGFB1—hematologic cancer	5.74e-06	0.000208	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—NRAS—hematologic cancer	5.71e-06	0.000207	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—EP300—hematologic cancer	5.71e-06	0.000206	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	5.67e-06	0.000205	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—DNMT3A—hematologic cancer	5.62e-06	0.000203	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—MYC—hematologic cancer	5.62e-06	0.000203	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—RB1—hematologic cancer	5.61e-06	0.000203	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—CDKN1B—hematologic cancer	5.58e-06	0.000202	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—ELL—hematologic cancer	5.54e-06	0.0002	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—EP300—hematologic cancer	5.48e-06	0.000198	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—MAPK3—hematologic cancer	5.47e-06	0.000198	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—TP53—hematologic cancer	5.44e-06	0.000197	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—CDKN2B—hematologic cancer	5.42e-06	0.000196	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—VEGFA—hematologic cancer	5.4e-06	0.000196	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—TNF—hematologic cancer	5.36e-06	0.000194	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	5.33e-06	0.000193	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—CCND1—hematologic cancer	5.32e-06	0.000193	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—NCOR2—hematologic cancer	5.32e-06	0.000192	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—TGFB1—hematologic cancer	5.31e-06	0.000192	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—FTCD—hematologic cancer	5.17e-06	0.000187	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GMPS—hematologic cancer	5.17e-06	0.000187	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PHYH—hematologic cancer	5.17e-06	0.000187	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—MAPK3—hematologic cancer	5.16e-06	0.000187	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—CDKN1A—hematologic cancer	5.15e-06	0.000186	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—NCOR1—hematologic cancer	5.14e-06	0.000186	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	5.11e-06	0.000185	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—MYC—hematologic cancer	5.02e-06	0.000182	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—RB1—hematologic cancer	5.01e-06	0.000181	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—IL6—hematologic cancer	4.98e-06	0.00018	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—CDKN2A—hematologic cancer	4.93e-06	0.000178	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—KRAS—hematologic cancer	4.92e-06	0.000178	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—MAPK3—hematologic cancer	4.91e-06	0.000178	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—AGO2—hematologic cancer	4.9e-06	0.000177	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—EP300—hematologic cancer	4.9e-06	0.000177	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	4.87e-06	0.000176	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	4.82e-06	0.000174	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—DNMT3B—hematologic cancer	4.8e-06	0.000174	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—H3F3B—hematologic cancer	4.8e-06	0.000174	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	4.78e-06	0.000173	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—MYC—hematologic cancer	4.78e-06	0.000173	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—SMPD3—hematologic cancer	4.72e-06	0.000171	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	4.71e-06	0.000171	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—TNF—hematologic cancer	4.63e-06	0.000168	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—PIK3CA—hematologic cancer	4.52e-06	0.000163	CbGpPWpGaD
Podofilox—TOP2A—Methyltestosterone—Prednisone—hematologic cancer	4.49e-06	0.00361	CbGdCrCtD
Podofilox—TOP2A—Cell Cycle—CDKN2A—hematologic cancer	4.41e-06	0.000159	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	4.4e-06	0.000159	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—RPS14—hematologic cancer	4.39e-06	0.000159	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—MAPK3—hematologic cancer	4.39e-06	0.000159	CbGpPWpGaD
Podofilox—TOP2A—Methyltestosterone—Prednisolone—hematologic cancer	4.38e-06	0.00353	CbGdCrCtD
Podofilox—TUBA4A—Hemostasis—TP53—hematologic cancer	4.37e-06	0.000158	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—CDKN1B—hematologic cancer	4.36e-06	0.000158	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—NUP98—hematologic cancer	4.33e-06	0.000157	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—IL6—hematologic cancer	4.32e-06	0.000156	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	4.29e-06	0.000155	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—MDM2—hematologic cancer	4.27e-06	0.000155	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—MYC—hematologic cancer	4.27e-06	0.000154	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—HRAS—hematologic cancer	4.18e-06	0.000151	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—NUP214—hematologic cancer	4.17e-06	0.000151	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—CCND1—hematologic cancer	4.16e-06	0.000151	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ASNS—hematologic cancer	4.13e-06	0.000149	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—B3GAT1—hematologic cancer	4.13e-06	0.000149	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—DCK—hematologic cancer	4.13e-06	0.000149	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—TP53—hematologic cancer	4.12e-06	0.000149	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	4.05e-06	0.000147	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—ESR1—hematologic cancer	4.04e-06	0.000146	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	4.04e-06	0.000146	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—CDKN1A—hematologic cancer	4.03e-06	0.000146	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	4e-06	0.000145	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—HDC—hematologic cancer	3.91e-06	0.000142	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—NOTCH1—hematologic cancer	3.9e-06	0.000141	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—CDKN1B—hematologic cancer	3.9e-06	0.000141	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—EIF4EBP1—hematologic cancer	3.84e-06	0.000139	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—HSPB1—hematologic cancer	3.84e-06	0.000139	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—EP300—hematologic cancer	3.83e-06	0.000139	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—IL6—hematologic cancer	3.74e-06	0.000135	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	3.72e-06	0.000135	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—CCND1—hematologic cancer	3.72e-06	0.000135	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—AKT1—hematologic cancer	3.69e-06	0.000134	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—SMC1A—hematologic cancer	3.68e-06	0.000133	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	3.67e-06	0.000133	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	3.65e-06	0.000132	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—H3F3A—hematologic cancer	3.61e-06	0.00013	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—CDKN1A—hematologic cancer	3.6e-06	0.00013	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CDA—hematologic cancer	3.58e-06	0.00013	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—CREBBP—hematologic cancer	3.54e-06	0.000128	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—TP53—hematologic cancer	3.51e-06	0.000127	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—EZH2—hematologic cancer	3.46e-06	0.000125	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PC—hematologic cancer	3.45e-06	0.000125	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—MAPK3—hematologic cancer	3.43e-06	0.000124	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—EP300—hematologic cancer	3.43e-06	0.000124	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—PARP1—hematologic cancer	3.39e-06	0.000122	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—MYC—hematologic cancer	3.34e-06	0.000121	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—SLC35B2—hematologic cancer	3.33e-06	0.00012	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GBA—hematologic cancer	3.33e-06	0.00012	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—HDAC2—hematologic cancer	3.27e-06	0.000118	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—FTCD—hematologic cancer	3.11e-06	0.000112	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GMPS—hematologic cancer	3.11e-06	0.000112	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PHYH—hematologic cancer	3.11e-06	0.000112	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—MAPK3—hematologic cancer	3.07e-06	0.000111	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—MTAP—hematologic cancer	3.04e-06	0.00011	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—MYC—hematologic cancer	2.99e-06	0.000108	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—SMPD3—hematologic cancer	2.84e-06	0.000103	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—AR—hematologic cancer	2.83e-06	0.000102	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—FHL2—hematologic cancer	2.71e-06	9.82e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—AGRN—hematologic cancer	2.66e-06	9.63e-05	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—CDKN2B—hematologic cancer	2.61e-06	9.44e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—IDH2—hematologic cancer	2.52e-06	9.13e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—HMMR—hematologic cancer	2.52e-06	9.13e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—B3GAT1—hematologic cancer	2.48e-06	8.98e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ASNS—hematologic cancer	2.48e-06	8.98e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—DCK—hematologic cancer	2.48e-06	8.98e-05	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—NCOR1—hematologic cancer	2.48e-06	8.96e-05	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—TP53—hematologic cancer	2.45e-06	8.87e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	2.38e-06	8.61e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ARNTL—hematologic cancer	2.37e-06	8.58e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—HDC—hematologic cancer	2.35e-06	8.52e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ACP5—hematologic cancer	2.31e-06	8.35e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CA9—hematologic cancer	2.31e-06	8.35e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—NCOR2—hematologic cancer	2.28e-06	8.24e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—IDH1—hematologic cancer	2.17e-06	7.85e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CDA—hematologic cancer	2.15e-06	7.79e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ABCC3—hematologic cancer	2.14e-06	7.76e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—TXN—hematologic cancer	2.14e-06	7.76e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GSTO1—hematologic cancer	2.14e-06	7.76e-05	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—MYC—hematologic cancer	2.1e-06	7.6e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—SPHK1—hematologic cancer	2.1e-06	7.59e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PC—hematologic cancer	2.07e-06	7.5e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—UGT1A1—hematologic cancer	2.02e-06	7.3e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GBA—hematologic cancer	2e-06	7.24e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—SLC35B2—hematologic cancer	2e-06	7.24e-05	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—MAPK14—hematologic cancer	1.98e-06	7.17e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—SLC22A1—hematologic cancer	1.96e-06	7.1e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CRABP1—hematologic cancer	1.96e-06	7.1e-05	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—ESR1—hematologic cancer	1.94e-06	7.03e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ALOX5—hematologic cancer	1.91e-06	6.92e-05	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—NOTCH1—hematologic cancer	1.88e-06	6.8e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—NUP98—hematologic cancer	1.85e-06	6.7e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—MTAP—hematologic cancer	1.83e-06	6.62e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—NCOA3—hematologic cancer	1.8e-06	6.5e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ADCY7—hematologic cancer	1.8e-06	6.5e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—NUP214—hematologic cancer	1.78e-06	6.46e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.77e-06	6.39e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ABCG2—hematologic cancer	1.75e-06	6.33e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—MTR—hematologic cancer	1.75e-06	6.33e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ENO2—hematologic cancer	1.71e-06	6.2e-05	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—CREBBP—hematologic cancer	1.7e-06	6.17e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GSTT1—hematologic cancer	1.66e-06	6.02e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.64e-06	5.92e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—FHL2—hematologic cancer	1.63e-06	5.9e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—SDC1—hematologic cancer	1.63e-06	5.88e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—AGRN—hematologic cancer	1.6e-06	5.79e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.55e-06	5.62e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.53e-06	5.55e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—HMMR—hematologic cancer	1.52e-06	5.49e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—IDH2—hematologic cancer	1.52e-06	5.49e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.47e-06	5.3e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ARNTL—hematologic cancer	1.43e-06	5.16e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ACP5—hematologic cancer	1.39e-06	5.02e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CA9—hematologic cancer	1.39e-06	5.02e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CD44—hematologic cancer	1.38e-06	5e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—NQO1—hematologic cancer	1.38e-06	5e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—NCOR2—hematologic cancer	1.37e-06	4.95e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.35e-06	4.9e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CYCS—hematologic cancer	1.31e-06	4.73e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—IDH1—hematologic cancer	1.3e-06	4.72e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	1.3e-06	4.7e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GSTO1—hematologic cancer	1.29e-06	4.67e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—TXN—hematologic cancer	1.29e-06	4.67e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ABCC3—hematologic cancer	1.29e-06	4.67e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—SPHK1—hematologic cancer	1.26e-06	4.57e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—UGT1A1—hematologic cancer	1.21e-06	4.39e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—SLC22A1—hematologic cancer	1.18e-06	4.27e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CRABP1—hematologic cancer	1.18e-06	4.27e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.17e-06	4.23e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GSTP1—hematologic cancer	1.15e-06	4.17e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ALOX5—hematologic cancer	1.15e-06	4.16e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.12e-06	4.04e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—NUP98—hematologic cancer	1.11e-06	4.03e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ABCB1—hematologic cancer	1.09e-06	3.95e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ADCY7—hematologic cancer	1.08e-06	3.91e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—NCOA3—hematologic cancer	1.08e-06	3.91e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—NUP214—hematologic cancer	1.07e-06	3.88e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—NCOR1—hematologic cancer	1.06e-06	3.83e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GSTM1—hematologic cancer	1.06e-06	3.83e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ABCG2—hematologic cancer	1.05e-06	3.8e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—MTR—hematologic cancer	1.05e-06	3.8e-05	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—MAPK3—hematologic cancer	1.04e-06	3.76e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ENO2—hematologic cancer	1.03e-06	3.73e-05	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—MYC—hematologic cancer	1.01e-06	3.66e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GSTT1—hematologic cancer	1e-06	3.62e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—SDC1—hematologic cancer	9.77e-07	3.54e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—MTHFR—hematologic cancer	9.36e-07	3.39e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CD44—hematologic cancer	8.31e-07	3.01e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—NQO1—hematologic cancer	8.31e-07	3.01e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	8.25e-07	2.98e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PIK3CG—hematologic cancer	7.87e-07	2.85e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CYCS—hematologic cancer	7.86e-07	2.85e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	7.81e-07	2.83e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CREBBP—hematologic cancer	7.29e-07	2.64e-05	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—AKT1—hematologic cancer	7.01e-07	2.54e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GSTP1—hematologic cancer	6.93e-07	2.51e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PIK3CD—hematologic cancer	6.92e-07	2.5e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ALB—hematologic cancer	6.83e-07	2.47e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ABCB1—hematologic cancer	6.56e-07	2.37e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PIK3R1—hematologic cancer	6.53e-07	2.36e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—NCOR1—hematologic cancer	6.37e-07	2.3e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GSTM1—hematologic cancer	6.37e-07	2.3e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PIK3CB—hematologic cancer	6.03e-07	2.18e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—MTHFR—hematologic cancer	5.63e-07	2.04e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PTEN—hematologic cancer	5.21e-07	1.88e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—EP300—hematologic cancer	4.97e-07	1.8e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PIK3CG—hematologic cancer	4.73e-07	1.71e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CREBBP—hematologic cancer	4.39e-07	1.59e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PIK3CD—hematologic cancer	4.16e-07	1.5e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ALB—hematologic cancer	4.1e-07	1.49e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PIK3R1—hematologic cancer	3.93e-07	1.42e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PIK3CA—hematologic cancer	3.67e-07	1.33e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PIK3CB—hematologic cancer	3.62e-07	1.31e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PTEN—hematologic cancer	3.13e-07	1.13e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—AKT1—hematologic cancer	3e-07	1.09e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—EP300—hematologic cancer	2.99e-07	1.08e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PIK3CA—hematologic cancer	2.21e-07	7.99e-06	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—AKT1—hematologic cancer	1.8e-07	6.53e-06	CbGpPWpGaD
